Pharmacokinetics Clinical Trials

33 recruitingLast updated: July 25, 2026

There are 33 actively recruiting pharmacokinetics clinical trials across 12 countries. Studies span Phase 1, Not Applicable, Phase 4, Phase 2, Phase 3. Top locations include Shanghai, Shanghai Municipality, China, Baltimore, Maryland, United States, Ghent, Belgium. Updated daily from ClinicalTrials.gov.


Pharmacokinetics Trials at a Glance

33 actively recruiting trials for pharmacokinetics are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Phase 1 with 13 trials, with the heaviest enrollment activity in Shanghai, Baltimore, and Ghent. Lead sponsors running pharmacokinetics studies include Children's Hospital of Fudan University, Johns Hopkins University, and University Hospital, Ghent.

Browse pharmacokinetics trials by phase

Treatments under study

About Pharmacokinetics Clinical Trials

Looking for clinical trials for Pharmacokinetics? There are currently 22 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pharmacokinetics trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pharmacokinetics clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 33 trials

Recruiting
Phase 1

Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination

Healthy VolunteerSafetyPharmacokinetics+2 more
Basilea Pharmaceutica96 enrolled1 locationNCT06733675
Recruiting
Phase 1

A Study to Investigate the Pharmacokinetics and ECG Effects of Linaprazan Glurate

Safety and TolerabilityPharmacokineticsGERD+1 more
Cinclus Pharma Holding AB121 enrolled1 locationNCT05469854
Recruiting
Phase 4

Liposomal Bupivacaine Versus Plain Bupivacaine After Intercostal Injections For Pain Management After Thoracoscopy

Pain, PostoperativePharmacokinetics
Milton S. Hershey Medical Center40 enrolled1 locationNCT03737292
Recruiting
Phase 1

Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)

Healthy VolunteerPharmacokinetics
Ensysce Biosciences54 enrolled1 locationNCT06500793
Recruiting
Not Applicable

Comparison of the Pharmacokinetics (PK)and Pharmacodynamics (PD)Biosimilarity of Insulin Aspart Injections After Single-Dose Subcutaneous Administration to Healthy Volunteers

Pharmacokinetics and Pharmacodynamics
Zhuhai United Laboratories Co., Ltd.44 enrolled1 locationNCT07600944
Recruiting
Not Applicable

Pharmacokinetics of Kava and Kratom Alone and in Combination

PharmacokineticsHerb-Herb Interaction
Botanic Tonics, LLC18 enrolled1 locationNCT07583407
Recruiting
Phase 4

Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing Strategies

AntibioticsPeriodontal DiseasesPharmacokinetics
University of Geneva, Switzerland45 enrolled1 locationNCT04669717
Recruiting
Phase 2Phase 3

Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar/Interchangeable Rapid-Acting Insulin Aspart (I004) and NovoLog® After Single-Dose Subcutaneous Administration to Healthy Volunteers

PharmacokineticsPharmacodynamicsInsulin Aspart
Amphastar Pharmaceuticals, Inc.60 enrolled1 locationNCT07560150
Recruiting
Phase 1

Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose

Healthy ParticipantsPharmacokinetics
Amgen400 enrolled5 locationsNCT07422285
Recruiting
Phase 1

Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in Adolescents

Pharmacokinetics After Oral Intake
Iterum Therapeutics, International Limited12 enrolled1 locationNCT07092813
Recruiting
Not Applicable

Kaempferol Absorption and Pharmacokinetics Evaluation

longevityHealthy VolunteersNo Disease+2 more
University of Pittsburgh120 enrolled3 locationsNCT07322406
Recruiting
Phase 4

Investigating the Pharmacokinetics of Tafenoquine in Healthy Papua New Guinean Children

Pharmacokinetics of Tafenoquine
Curtin University30 enrolled1 locationNCT07052162
Recruiting

PK/PD of Caspofungin in Children Severe Infection

PharmacokineticsInfection, Fungal
Children's Hospital of Fudan University60 enrolled2 locationsNCT04961593
Recruiting

Direct Observation Study of Kratom Product Effects Among Regular Consumers

Kratom PharmacodynamicsKratom PharmacokineticsKratom
Johns Hopkins University22 enrolled1 locationNCT06089980
Recruiting

Antibiotic Dosing in Pediatric Intensive Care

PharmacokineticsAmoxicillin-clavulanatePiperacillin-tazobactam+5 more
University Hospital, Ghent640 enrolled1 locationNCT02456974
Recruiting
Not Applicable

Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)

PharmacokineticsAmoxicillin-clavulanatePiperacillin-tazobactam+6 more
University Hospital, Ghent300 enrolled3 locationsNCT06426836
Recruiting
Phase 1

Study of BB-025, Alone and After BB-031, in Healthy Volunteers

Healthy VolunteersPharmacokineticsPharmacodynamics
Basking Biosciences, Inc.72 enrolled1 locationNCT07202663
Recruiting
Phase 1

Safety, Tolerability, and Pharmacokinetics of RCS-21 in Healthy Volunteers.

SafetyHealthy VolunteersTolerability+1 more
RNATICS GmbH24 enrolled1 locationNCT06752122
Recruiting

Preliminary Characterization of Commercial Kratom Extract Products

Kratom PharmacodynamicsKratom Pharmacokinetics
Johns Hopkins University16 enrolled2 locationsNCT06640569
Recruiting
Phase 1

High Potency Cannabis: Acute and Protracted Effects

PainPharmacokineticsAbuse Cannabis
University of California, Los Angeles30 enrolled1 locationNCT06859723